Weiss Multi-Strategy Advisers’s Acceleron Pharma Inc. XLRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-77,714
| Closed | -$13.4M | – | 804 |
|
|
2021
Q3 | $13.4M | Buy |
77,714
+39,671
| +104% | +$6.83M | 0.29% | 114 |
|
|
2021
Q2 | $4.77M | Sell |
38,043
-32
| -0.1% | -$4.02K | 0.11% | 260 |
|
|
2021
Q1 | $5.16M | Sell |
38,075
-2,309
| -6% | -$313K | 0.11% | 244 |
|
|
2020
Q4 | $5.17M | Sell |
40,384
-3,001
| -7% | -$384K | 0.1% | 238 |
|
|
2020
Q3 | $4.88M | Buy |
43,385
+3,385
| +8% | +$381K | 0.13% | 221 |
|
|
2020
Q2 | $3.81M | Buy |
40,000
+2,776
| +7% | +$264K | 0.11% | 233 |
|
|
2020
Q1 | $3.35M | Buy |
37,224
+20,224
| +119% | +$1.82M | 0.13% | 203 |
|
|
2019
Q4 | $901K | Buy |
17,000
+11,500
| +209% | +$610K | 0.01% | 427 |
|
|
2019
Q3 | $217K | Buy |
5,500
+500
| +10% | +$19.7K | ﹤0.01% | 435 |
|
|
2019
Q2 | $205K | Hold |
5,000
| – | – | 0.01% | 385 |
|
|
2019
Q1 | $233K | Buy |
+5,000
| New | +$233K | 0.01% | 398 |
|
|
2017
Q2 | – | Sell |
-20,000
| Closed | -$529K | – | 621 |
|
|
2017
Q1 | $529K | Buy |
20,000
+5,000
| +33% | +$132K | 0.02% | 365 |
|
|
2016
Q4 | $383K | Sell |
15,000
-578
| -4% | -$14.8K | 0.02% | 300 |
|
|
2016
Q3 | $564K | Sell |
15,578
-460
| -3% | -$16.7K | 0.03% | 274 |
|
|
2016
Q2 | $545K | Sell |
16,038
-11,462
| -42% | -$389K | 0.04% | 279 |
|
|
2016
Q1 | $726K | Buy |
27,500
+5,000
| +22% | +$132K | 0.03% | 314 |
|
|
2015
Q4 | $1.1M | Sell |
22,500
-2,500
| -10% | -$122K | 0.08% | 196 |
|
|
2015
Q3 | $623K | Sell |
25,000
-1,000
| -4% | -$24.9K | 0.03% | 260 |
|
|
2015
Q2 | $823K | Buy |
26,000
+6,500
| +33% | +$206K | 0.03% | 293 |
|
|
2015
Q1 | $742K | Buy |
+19,500
| New | +$742K | 0.03% | 311 |
|